LWM
GEVA

LBA Wealth Management’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

LBA Wealth Management’s Portfolio GEVA Stock Details GEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-20
Closed -$2K – 342
2015
Q1 		$2K Hold
20
– – ﹤0.01% 301
2014
Q4 		$2K Hold
20
– – ﹤0.01% 284
2014
Q3 		$1K Buy
+20
New +$1.43K ﹤0.01% 424

LBA Wealth Management's GEVA Position: Q2 2015 in Review

LBA Wealth Management sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 20 shares — an estimated $2K sold.

LBA Wealth Management first reported a position in GEVA in Q3 2014 and held it in 3 quarters. The position peaked at $2K in Q1 2015. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

  • LBA Wealth Management reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • LBA Wealth Management sold 20 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $2K.
  • LBA Wealth Management first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q3 2014 and held it in 3 quarters.
  • LBA Wealth Management's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $2K in Q1 2015.
  • 0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on LBA Wealth Management's 13F filing for Q2 2015, filed 12 Aug 2015.